US Department of Veterans Affairs: Psychotic Disorders trials
The registry lists 17 Psychotic Disorders studies with US Department of Veterans Affairs as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 2 2Phase 3 2Phase 4 2No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Smoking Cessation for Veterans With Severe and Persistent Mental IllnessCompletedNCT00960375Phase 2/3Results posted
- Mindfulness Meditation as a Rehabilitation Strategy for Persons With SchizophreniaCompletedNCT00936351Not applicableResults posted
- A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)CompletedNCT00677898Not applicableResults posted
- The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.CompletedNCT00466323Not applicableResults posted
- Functional Rehabilitation of Older Patients With SchizophreniaCompletedNCT00237796Not applicableResults posted
- A Brief Community Linkage Intervention for Dually Diagnosed IndividualsCompletedNCT00137267Not applicableResults posted
- Long-Acting Injectable Risperidone in the Treatment of SchizophreniaCompletedNCT00132314Phase 3Results posted
- Contingency Management for Smoking Cessation Among Veterans With Psychotic DisordersTerminatedNCT00508560Not applicable
- A Study of Strategies to Improve Schizophrenia TreatmentCompletedNCT00156637Not applicable
- Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)CompletedNCT00119574Not applicable
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Generalization of Training in SchizophreniaCompletedNCT00108199Not applicable
- Psychiatric Advance Directives for Improved Mental Health CareCompletedNCT00105794Not applicable
- Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessCompletedNCT00057135Not applicable
- Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
- Cognitive - Behavioral TherapyCompletedNCT00018629Phase 2
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4